Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLOW AMI
NCT07898696Recruiting
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised trial of adenosine in ST elevation myocardial infarction (STEMI) (2 arms). Primary endpoint: Incidence of Slow-Flow or No-Reflow After PPCI at Day 1. Started Aug 2026; status: recruiting.
02
Drugs
adenosine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT07898696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07898696.